[144] Amphenol Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Amphenol Corporation (APH) shows a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $11,042,030.00 and reported shares outstanding of 1,220,921,111. The filing states the securities were acquired by exercise of options under a registered plan on 08/25/2025 and payment was in cash. The document also lists a sale by David Silverman of 100,000 common shares on 05/30/2025 that generated $8,909,350.00 in gross proceeds. The filer affirms no undisclosed material adverse information and includes the standard Rule 144 representations and signature warning regarding intentional misstatements.

Positive

• Transparent disclosure of the proposed sale details including broker, amount, market value, and acquisition method
• Compliance with Rule 144 including attestation about no undisclosed material adverse information

Negative

• Insider selling of 100,000 shares may be viewed negatively by some investors
• Inconsistent timeline appears between the acquisition date (08/25/2025) and a prior sale recorded on 05/30/2025 in the filing (both dates are shown in the document)

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for an insider-option exercise followed by proposed sale; appears procedural and consistent with executive liquidity.

The filing documents a proposed sale of 100,000 Amphenol common shares via a broker on the NYSE, acquired by exercising options under a registered plan and paid in cash. The disclosure includes a recent separate sale by the same named individual for the same number of shares in May, with gross proceeds listed. This is a standard compliance filing to notify the market under Rule 144 and does not by itself provide information about company performance. Investors should note timing and sizes of insider transactions but the filing contains only transactional detail without commentary on company fundamentals.

Corporate Governance Expert

TL;DR: The document is a compliance disclosure showing insider exercise and planned sale; it satisfies Rule 144 procedural requirements.

The form specifies method of acquisition (option exercise), payment method (cash), broker information, and a representation that no material non-public information is possessed. These elements meet typical governance and disclosure expectations. The presence of a prior sale by the same named person is noted in the filing, which is relevant for monitoring insider disposition patterns but does not by itself indicate governance concerns. All required attestations and warnings are present in the remarks section.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	11042030.00	1220921111	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2025	Exercise of options under a registered plan	Issuer			100000	08/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID SILVERMAN 358 Hall Avenue Wallingford CT 06492	Common	05/30/2025	100000	8909350.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Amphenol Corporation (APH) report?

The form reports a proposed sale of 100,000 common shares via Morgan Stanley on the NYSE with an aggregate market value of $11,042,030.00 and states the shares were acquired by option exercise.

Who is listed as the seller in the filing?

The filing names David Silverman in the section listing securities sold during the past three months, showing a sale of 100,000 shares on 05/30/2025 for $8,909,350.00 gross proceeds.

How were the securities acquired according to the filing?

The securities to be sold were acquired by exercise of options under a registered plan with the acquisition date listed as 08/25/2025 and payment in cash.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY; the sale is to occur on the NYSE.

Does the filing state any undisclosed material information about Amphenol?

The person for whose account the securities are to be sold represents by signing the notice that they do not know any material adverse information that has not been publicly disclosed.